<DOC>
	<DOCNO>NCT01179516</DOCNO>
	<brief_summary>The purpose study evaluate efficacy , safety tolerability vortioxetine , daily ( QD ) , compare placebo adult major depressive disorder .</brief_summary>
	<brief_title>Safety Efficacy Study Vortioxetine ( Lu AA21004 ) Adults With Major Depressive Disorder</brief_title>
	<detailed_description>The drug test study call Vortioxetine . Vortioxetine test treat depression adult major depressive disorder ( MDD ) . This study look MDD relief people take vary dosage vortioxetine . The study enrol 469 patient . Participants randomly assign ( chance , like flip coin ) one three treatment groups—which remain undisclosed patient study doctor study ( unless urgent medical need ) : - Vortioxetine 10 mg - Vortioxetine 15 mg - Placebo ( dummy inactive capsule ) - capsule look like study drug active ingredient . All participant ask take one capsule time day throughout study . This multi-center trial conduct United States . The overall time participate study 14 week . Participants make 7 visit clinic , contact telephone 4 week last dose study drug follow-up assessment .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Vortioxetine</mesh_term>
	<criteria>Suffers major depressive episode ( MDE ) recurrent primary diagnosis accord Diagnostic Statistical Manual Mental Disorders , Fourth Edition , Text Revision ( DSMIVTR ) criterion . The report duration current MDE least 3 month . Has Montgomery Åsberg Depression Rating Scale ( MADRS ) total score 26 great Screening Baseline Visits . Has Clinical Global Impression Severity Illness ( CGIS ) score 4 great Screening Baseline Visits . Has receive investigational compound &lt; 30 day Screening 5 halflives prior Screening . Has receive Lu AA21004 previous clinical study . Has 1 follow : 1 . Any current psychiatric disorder MDD define DSMIVTR . 2 . Current history : manic hypomanic episode , schizophrenia psychotic disorder , include major depression psychotic feature , mental retardation , organic mental disorder , mental disorder due general medical condition define DSMIVTR . 3 . Diagnosis alcohol substance abuse dependence ( exclude nicotine caffeine ) define DSMIVTR sustain full remission least 2 year prior Screening . 4 . Presence history clinically significant neurological disorder ( include epilepsy ) . 5 . Neurodegenerative disorder ( Alzheimer disease , Parkinson disease , multiple sclerosis , Huntington disease , etc ) . 6 . Any Axis II disorder might compromise study . The current depressive symptom patient consider investigator resistant 2 adequate antidepressant treatment least 6 week duration . Has receive electroconvulsive therapy , vagal nerve stimulation , repetitive transcranial magnetic stimulation within 6 month prior Screening . Was currently receive formal cognitive behavioral therapy , systematic psychotherapy , plan initiate therapy study . Has significant risk suicide accord investigator 's clinical judgment score ≥5 item 10 ( suicidal thought ) MADRS make suicide attempt previous 6 month . Was require take excluded medication anticipate would require treatment least 1 disallow concomitant medication study . Has clinically significant unstable illness , example hepatic impairment renal insufficiency , cardiovascular , pulmonary , gastrointestinal , endocrine , neurological , rheumatologic , immunologic , hematological , infectious , dermatological disorder metabolic disturbance . NOTE : For purpose study , follow condition consider unstable due potential impact assessment MDD response : pain disorder , chronic fatigue syndrome , fibromyalgia , obstructive sleep apnea . Has 1 laboratory value outside normal range , base blood urine sample take Screening Visit , consider investigator clinically significant ; patient follow value Screening Visit : 1 . A serum creatinine value &gt; 1.5 time upper limit normal ( × ULN ) . 2 . A total serum total bilirubin value &gt; 1.5 × ULN . 3 . A serum alanine aminotransferase ( ALT ) aspartate aminotransferase ( AST ) value &gt; 2 × ULN . Has thyroid stimulate hormone value outside normal range . Has clinically significant abnormal vital sign . Has abnormal electrocardiogram .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Major Depressive Disorder</keyword>
	<keyword>Depression</keyword>
	<keyword>Drug Therapy</keyword>
</DOC>